Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Jun 13, 2012 at 12:55 PM EDT

Arena Volume Spike Highlights Weight Loss Sector Again, Volatility To Continue (ARNA, VVUS, OREX)

We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today. Shares are…

Paul Ausick | Jun 11, 2012 at 11:31 AM EDT

Revised Guidance Sinks Health Care Company (CNC, MOH, AGP, UNH, WCG)

To say that Centene Corp. (NYSE: CNC), a managed health care provider, has been on a roller coaster ride for…

Jon C. Ogg | Jun 8, 2012 at 8:36 AM EDT

Research Hints At Rite Aid Buyout With 61% Upside to Target (RAD, WAG, ESRX)

Rite Aid Corp. (NYSE: RAD) has been a troubled stock in a difficult financial position for over a decade now. …

Jon C. Ogg | Jun 5, 2012 at 8:16 AM EDT

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the…

Paul Ausick | Jun 4, 2012 at 12:44 PM EDT

Walgreen Hopes for the Best (WAG, ESRX, UNH, CVS, SXCI, CHSI)

Late last Friday, Walgreen Co. (NYSE: WAG) issued a brief statement on the company’s dispute with Express Scripts Inc. (NASDAQ:…

Jon C. Ogg | Jun 4, 2012 at 9:55 AM EDT

Merger Monday Heads to the Lab (MTOX, LH)

Merger and acquisition news has been a bit light of late, but there is at least one deal out there…

Jon C. Ogg | Jun 4, 2012 at 8:42 AM EDT

Biotech Movers, Mixed to Muted ASCO Results (AEZS, AUXL, IMGN, MDVN, DNDN)

We have several shares of biotech stocks on the move, but frankly the news from th American Society of Clinical…

Jon C. Ogg | May 29, 2012 at 8:04 AM EDT

Vertex ‘Correction’ to Cystic Fibrosis Destroys Billions in Value (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was very close to 52-week highs of late, but that will not be the case…

Jon C. Ogg | May 21, 2012 at 12:12 PM EDT

Some Added Hope For Dendreon

AuthorDendreon Corporation (NASDAQ: DNDN) needs all the goods news it can get. While the American Society for Clinical Oncology (ASCO)…

Jon C. Ogg | May 21, 2012 at 10:05 AM EDT

Does DaVita Acquisition Make Warren Buffett Rethink His Kidney Dialysis Bet?

DaVita Inc. (NYSE: DVA) is facing a bit of a drag on its announcement that it is spending some $4.4…

Jon C. Ogg | May 18, 2012 at 7:47 AM EDT

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012…

Jon C. Ogg | May 17, 2012 at 11:35 AM EDT

Dendreon In Trouble

AuthorDendreon Corporation (NASDAQ: DNDN) is in trouble. That is what the performance is telling investors. The maker of Provenge as…

Jon C. Ogg | May 17, 2012 at 8:58 AM EDT

IPO Filing From KYTHERA: Fighting The Double Chin

KYTHERA Biopharmaceuticals, Inc. has just joined in with the companies which have filed to come public via an initial public…

Jon C. Ogg | May 17, 2012 at 7:34 AM EDT

Rosetta Genomics Share Offering: No Good Deeds Go Unpunished

Rosetta Genomics, Ltd. (NASDAQ: ROSG) was an exponential winner on Wednesday due to getting a Medicare reimbursement ruling in its…

Jon C. Ogg | May 16, 2012 at 10:25 AM EDT

Rosetta Genomics Joins Exponential Explosion Club on Medicare Coverage

Rosetta Genomics Ltd. (NASDAQ: ROSG) is not often in the news, but it is in the news a big way…

1 … 317 318 319 320 321 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Arena Volume Spike Highlights Weight Loss Sector Again, Volatility To Continue (ARNA, VVUS, OREX)

Revised Guidance Sinks Health Care Company (CNC, MOH, AGP, UNH, WCG)

Research Hints At Rite Aid Buyout With 61% Upside to Target (RAD, WAG, ESRX)

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Walgreen Hopes for the Best (WAG, ESRX, UNH, CVS, SXCI, CHSI)

Merger Monday Heads to the Lab (MTOX, LH)

Biotech Movers, Mixed to Muted ASCO Results (AEZS, AUXL, IMGN, MDVN, DNDN)

Vertex ‘Correction’ to Cystic Fibrosis Destroys Billions in Value (VRTX)

Some Added Hope For Dendreon

Does DaVita Acquisition Make Warren Buffett Rethink His Kidney Dialysis Bet?

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Dendreon In Trouble

IPO Filing From KYTHERA: Fighting The Double Chin

Rosetta Genomics Share Offering: No Good Deeds Go Unpunished

Rosetta Genomics Joins Exponential Explosion Club on Medicare Coverage

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Arena Volume Spike Highlights Weight Loss Sector Again, Volatility To Continue (ARNA, VVUS, OREX)

Revised Guidance Sinks Health Care Company (CNC, MOH, AGP, UNH, WCG)

Research Hints At Rite Aid Buyout With 61% Upside to Target (RAD, WAG, ESRX)

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Walgreen Hopes for the Best (WAG, ESRX, UNH, CVS, SXCI, CHSI)

Merger Monday Heads to the Lab (MTOX, LH)

Biotech Movers, Mixed to Muted ASCO Results (AEZS, AUXL, IMGN, MDVN, DNDN)

Vertex ‘Correction’ to Cystic Fibrosis Destroys Billions in Value (VRTX)

Some Added Hope For Dendreon

Does DaVita Acquisition Make Warren Buffett Rethink His Kidney Dialysis Bet?

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

Dendreon In Trouble

IPO Filing From KYTHERA: Fighting The Double Chin

Rosetta Genomics Share Offering: No Good Deeds Go Unpunished

Rosetta Genomics Joins Exponential Explosion Club on Medicare Coverage

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation